Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Maltol in Pulmonary Hypertension and Iron Deficiency Anemia
NCT03371173Phase 3Terminated
- Sponsor
- Hannover Medical School
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric maltol in iron deficiency anemia (IDA), sponsored by Hannover Medical School. Started Mar 2018; status: terminated.
02
Drugs
ferric maltol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03371173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371173.